A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

Inclusion Criteria: * Male and female patients 12 years and older with a compatible history greater than or equal to 1 year of rhinitis due to perennial allergies. * Must be willing and able to provide informed consent and to participate in all study procedures * Must be in generally good health * Positive skin test to a prevalent perennial allergen Exclusion Criteria: * On nasal examination, the presence of nasal mucosal erosion, nasal ulceration or nasal septal perforation * Use of any investigational drug within 30 days of the first visit * Any nasal surgery or sinus surgery within the previous year * Presence of any hypersensitivity to drugs similar to azelastine or mometasone furoate and to either sorbital or sucralose * Women who are pregnant or nursing * Women who are not using an acceptable method of birth control * Nasal Diseases likely to affect deposition of intranasal medication, such as sinusitis, rhinitis medicamentosa or clinically significant nasal polyposis or nasal structural abnormalities. * Asthma or other lung diseases such as COPD. Mild asthma symptoms may be considered after consultation with investigator. * Patients with Arrythmia * Patients with know history of alcohol and drug abuse * Existence of any surgical or medical condition, which in the opinion of the investigator or sponsor, might significantly alter the evaluation of the study. * Use of medications that could affect the study results